Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj
CAS TSIS TAU: 1508250-71-2
Cov mis mos molecular: C26H31ClN6O2
Molecular phaus: 495.01600
EINECS NO: Tsis yog
MDL NO: NA
Khoom Piav Qhia:
Khoom Lub Npe: Nazartinib CAS TSIS TAU: 1508250-71-2
Lub ntsiab lus:
(R, E) -N- (7-chloro-1- (1- (4- (dimethylamino) but-2-enoyl) azepan-3-yl) -1H-benzo [d] imidazol-2-yl)- 2-methylisonicotinamide;
EGF816;
Tshuaj& Lub Cev Muaj Zog:
Tshwm sim: Cov hmoov av
Kev Ntsuas: ≥98.0%
Ceev: 1.28 ± 0.1 g/cm3 (Kwv yees)
PKa: 11.38 ± 0.43 (Kwv yees)
Dej Solubility: Insoluble
Index ntawm Refraction: 1.643
Soluble: Soluble hauv DMSO
Kev Cia Cia: Qhuav, tsaus thiab ntawm 0 - 4 ℃ rau lub sijhawm luv (hnub mus rau lub lim tiam) lossis -20 ℃ rau lub sijhawm ntev (hli mus rau xyoo).
Nazartinib (EGF816, NVS-816) yog covalent, tsis hloov pauv, xaiv cov tshuaj tiv thaiv kev hloov pauv ntawm EGFR. Nws muaj nanomolar inhibitory effect rau hloov pauv EGFR (L858R, Ex19Del) thiab T790M. Nws yog qhov tshwj xeeb tshaj rau mutant EGFR.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!
Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.
Cim npe nrov: nazartinib cas 1508250-71-2, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag
